[Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].
Identifieur interne : 00DD40 ( Main/Exploration ); précédent : 00DD39; suivant : 00DD41[Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].
Auteurs : H. LindemayrSource :
- Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [ 0017-8470 ] ; 1989.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Kératolytiques, Produits dermatologiques, Urée.
- traitement médicamenteux : Kératose.
- Administration par voie topique, Association thérapeutique, Humains, Insuffisance veineuse, Lymphoedème.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Dermatologic Agents, Keratolytic Agents, Urea.
- complications : Lymphedema, Venous Insufficiency.
- drug therapy : Keratosis.
- Administration, Topical, Combined Modality Therapy, Humans.
Abstract
Due to keratolytic and epidermis-thinning effects 10% urea/w/o is effective in the treatment of papillomatosis cutis verrucosa (lymphostatic papillomatosis). If possible, compression bandages should be used. Indirect lymphography reveals abnormalities of dermal lymphdrainage in papillomatosis cutis verrucosa.
PubMed: 2807931
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 006042
- to stream PubMed, to step Curation: 006042
- to stream PubMed, to step Checkpoint: 006042
- to stream Ncbi, to step Merge: 008C01
- to stream Ncbi, to step Curation: 008C01
- to stream Ncbi, to step Checkpoint: 008C01
- to stream Main, to step Merge: 00E956
- to stream Main, to step Curation: 00DD40
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].</title><author><name sortKey="Lindemayr, H" sort="Lindemayr, H" uniqKey="Lindemayr H" first="H" last="Lindemayr">H. Lindemayr</name><affiliation><nlm:affiliation>II. Universitäts-Hautklinik Wien.</nlm:affiliation><wicri:noCountry code="no comma">II. Universitäts-Hautklinik Wien.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1989">1989</date><idno type="RBID">pubmed:2807931</idno><idno type="pmid">2807931</idno><idno type="wicri:Area/PubMed/Corpus">006042</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006042</idno><idno type="wicri:Area/PubMed/Curation">006042</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006042</idno><idno type="wicri:Area/PubMed/Checkpoint">006042</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006042</idno><idno type="wicri:Area/Ncbi/Merge">008C01</idno><idno type="wicri:Area/Ncbi/Curation">008C01</idno><idno type="wicri:Area/Ncbi/Checkpoint">008C01</idno><idno type="wicri:doubleKey">0017-8470:1989:Lindemayr H:treatment:success:using</idno><idno type="wicri:Area/Main/Merge">00E956</idno><idno type="wicri:Area/Main/Curation">00DD40</idno><idno type="wicri:Area/Main/Exploration">00DD40</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].</title><author><name sortKey="Lindemayr, H" sort="Lindemayr, H" uniqKey="Lindemayr H" first="H" last="Lindemayr">H. Lindemayr</name><affiliation><nlm:affiliation>II. Universitäts-Hautklinik Wien.</nlm:affiliation><wicri:noCountry code="no comma">II. Universitäts-Hautklinik Wien.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete</title><idno type="ISSN">0017-8470</idno><imprint><date when="1989" type="published">1989</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Topical</term><term>Combined Modality Therapy</term><term>Dermatologic Agents (administration & dosage)</term><term>Humans</term><term>Keratolytic Agents (administration & dosage)</term><term>Keratosis (drug therapy)</term><term>Lymphedema (complications)</term><term>Urea (administration & dosage)</term><term>Venous Insufficiency (complications)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie topique</term><term>Association thérapeutique</term><term>Humains</term><term>Insuffisance veineuse ()</term><term>Kératolytiques (administration et posologie)</term><term>Kératose (traitement médicamenteux)</term><term>Lymphoedème ()</term><term>Produits dermatologiques (administration et posologie)</term><term>Urée (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dermatologic Agents</term><term>Keratolytic Agents</term><term>Urea</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Kératolytiques</term><term>Produits dermatologiques</term><term>Urée</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term><term>Venous Insufficiency</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Keratosis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Kératose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Topical</term><term>Combined Modality Therapy</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie topique</term><term>Association thérapeutique</term><term>Humains</term><term>Insuffisance veineuse</term><term>Lymphoedème</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Due to keratolytic and epidermis-thinning effects 10% urea/w/o is effective in the treatment of papillomatosis cutis verrucosa (lymphostatic papillomatosis). If possible, compression bandages should be used. Indirect lymphography reveals abnormalities of dermal lymphdrainage in papillomatosis cutis verrucosa.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Lindemayr, H" sort="Lindemayr, H" uniqKey="Lindemayr H" first="H" last="Lindemayr">H. Lindemayr</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00DD40 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00DD40 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:2807931
|texte= [Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:2807931" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |